A E Grzegorzewska
Grzegorzewska A, Niepolski L, Świderska M, Mostowska A, Stolarek I, Warchoł W, et al
. ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients. BMC Med Genet. 2018;19:194 pubmed publisher
..Differences in the availability of transcription binding sites may contribute to these associations. ..
Grzegorzewska A, Młot Michalska M, Wobszal P. Does ingestion of regular coffee influence serum lipid profile in dialysis patients?. Adv Perit Dial. 2009;25:181-6 pubmed
Grzegorzewska A, Pajzderski D, Sowińska A, Mostowska A, Jagodziński P. IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection. Vaccine. 2013;31:1766-70 pubmed publisher
..8%, CC 3.8%; IL13 CC 60.5%, CT 34.6%, TT 4.9%). In HD patients, neither the IL4R nor IL13 polymorphism is associated with anti-HBs development irrespective of whether an immunization is provoked by HBV vaccination or HBV infection. ..
Grzegorzewska A, CieszyÅ„ski K, Niepolski L, Kaczmarek A, SowiÅ„ska A. Serum cardiac troponin T and effective blood flow in stable extracorporeal dialysis patients. Int Urol Nephrol. 2016;48:419-29 pubmed publisher
..In stable ED patients, higher eQB rates and QB/QD values might contribute to silent myocardial injury, particularly in patients with lower cTnT levels, but do not affect the outcome of ED patients. ..
Grzegorzewska A, Kaczmarek Leki V, Młot Michalska M, Niepolski L. Seroconversion rate to positivity for antibodies against core antigen of hepatitis B virus and duration of renal replacement therapy. Nephrol Dial Transplant. 2011;26:970-6 pubmed publisher
..112, P = 0.04). Seroconversion rate to anti-HBc positivity is not related to duration of RRT treatment but to ineffective vaccination against HBV. ..
Grzegorzewska A, Åšwiderska M, Mostowska A, WarchoÅ‚ W, JagodziÅ„ski P. Polymorphisms of T helper cell cytokine-associated genes and survival of hemodialysis patients - a prospective study. BMC Nephrol. 2017;18:165 pubmed publisher
..035). In multivariate analyses, however, the mentioned polymorphisms were not independent predictors of survival. Polymorphisms of IFNL3 rs8099917 and IL12A rs568408 contribute to survival of HD patients, but not as independent factors. ..
Grzegorzewska A, Niepolski L, Mostowska A, Warchoł W, Jagodziński P. Involvement of adropin and adropin-associated genes in metabolic abnormalities of hemodialysis patients. Life Sci. 2016;160:41-46 pubmed publisher
..In HD patients, lower plasma adropin concentration is associated with dyslipidemia. Major homozygosity of RXRA seems to have an opposite effect on plasma adropin compared with that of ENHO rs2281997. ..
Grzegorzewska A, Młot M. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease. Rocz Akad Med Bialymst. 2004;49:190-2 pubmed
..We checked correlation of CAP/CIP with osteoprotegrin (OPG), its soluble ligand (OPGL) and routinely measured parameters of bone turnover in patients treated with peritoneal dialysis (PD) and hemodialysis (HD)...
Grzegorzewska A. [Metabolic syndrome in dialyzed patients. Advanced glycation end-products, adipocytokines, and principles of treatment]. Pol Merkur Lekarski. 2010;28:244-6 pubmed
..Attention was paid for therapeutic aspects, associated with treatment of end-stage renal disease and with dialysis procedure, which may influence the course of MeS...